ACAD
Price
$18.49
Change
+$0.29 (+1.59%)
Updated
Mar 28, 6:59 PM EST
33 days until earnings call
ROIV
Price
$10.54
Change
-$0.30 (-2.77%)
Updated
Mar 28, 6:59 PM EST
89 days until earnings call
Ad is loading...

Analysis and predictions ACAD vs ROIV

Header iconACAD vs ROIV Comparison
Open Charts ACAD vs ROIVBanner chart's image
ACADIA Pharmaceuticals
Price$18.49
Change+$0.29 (+1.59%)
Volume$955.97K
CapitalizationN/A
Roivant Sciences
Price$10.54
Change-$0.30 (-2.77%)
Volume$37.72M
CapitalizationN/A
View a ticker or compare two or three
ACAD vs ROIV Comparison Chart

Loading...

ACADDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ROIVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ACAD vs. ROIV commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Hold and ROIV is a Sell.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (ACAD: $18.46 vs. ROIV: $10.54)
Brand notoriety: ACAD and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 61% vs. ROIV: 906%
Market capitalization -- ACAD: $3.04B vs. ROIV: $8.49B
ACAD [@Biotechnology] is valued at $3.04B. ROIV’s [@Biotechnology] market capitalization is $8.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 1 green FA rating(s).

  • ACAD’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than ACAD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 6 bullish TA indicator(s).

  • ACAD’s TA Score: 4 bullish, 4 bearish.
  • ROIV’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than ACAD.

Price Growth

ACAD (@Biotechnology) experienced а +0.27% price change this week, while ROIV (@Biotechnology) price change was +2.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

ACAD is expected to report earnings on May 01, 2024.

ROIV is expected to report earnings on Jun 26, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ACAD with price predictions.
OPEN
A.I.dvisor published
a Summary for ROIV with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ROIV($8.49B) has a higher market cap than ACAD($3.04B). ROIV YTD gains are higher at: -6.144 vs. ACAD (-41.041). ROIV has higher annual earnings (EBITDA): 4.33B vs. ACAD (-67.83M). ROIV has more cash in the bank: 6.67B vs. ACAD (439M). ACAD has less debt than ROIV: ACAD (57.2M) vs ROIV (507M). ACAD has higher revenues than ROIV: ACAD (726M) vs ROIV (123M).
ACADROIVACAD / ROIV
Capitalization3.04B8.49B36%
EBITDA-67.83M4.33B-2%
Gain YTD-41.041-6.144668%
P/E RatioN/A2.00-
Revenue726M123M590%
Total Cash439M6.67B7%
Total Debt57.2M507M11%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADROIV
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
57%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
60%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 4 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
66%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Ad is loading...
ACADDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ROIVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GDXU31.101.98
+6.80%
MicroSectors™ Gold Miners 3X Lvrgd ETN
WFIG44.32-0.01
-0.03%
WisdomTree US Corporate Bond
VMBS45.61-0.14
-0.31%
Vanguard Mortgage-Backed Secs ETF
IQDY28.79-0.16
-0.55%
FlexShares Intl Qual Div Dynamic ETF
IVOL18.93-0.15
-0.78%
Quadratic Intrst Rt Vol & Infl H ETF

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-2.77%
IMVT - ROIV
59%
Loosely correlated
-0.80%
FOLD - ROIV
44%
Loosely correlated
-0.93%
AXON - ROIV
43%
Loosely correlated
-0.98%
IONS - ROIV
40%
Loosely correlated
-2.93%
RVMD - ROIV
40%
Loosely correlated
+1.51%
More